Symic Biomedical is a healthcare company that specializes in biotechnology. The company focuses on developing matrix regulator therapeutics that target damaged areas of the matrix, inhibiting pathological inflammatory responses. These therapeutics have applications in the areas of fibrosis, oncology, and diseases of the central nervous system. By binding to damaged targets, Symic Biomedical's therapeutics promote healing and prevent further damage.